GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vaidya Sane Ayurved Laboratories MADHAVBAUG.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

141.00

+3.71%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹898.5m

FY2019FY2025

Net income

₹71.4m

FY2019FY2025

Free cash flow

₹21.6m

FY2019FY2025

Shareholders' equity

₹625.4m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue₹898.5m₹993.3m₹991.7m₹747.1m₹522.7m₹752.3m₹625.0m
Gross profit₹730.9m₹736.2m₹715.5m₹515.9m₹346.5m₹527.5m₹448.5m
Operating income₹93.4m₹17.9m₹57.4m₹48.0m₹7.9m₹4.2m₹13.8m
Net income₹71.4m₹19.8m₹48.3m₹34.7m₹3.9m−₹5.6m₹5.0m
Diluted earnings per share5.781.574.603.300.37-0.53110.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets₹767.1m₹697.1m₹548.8m₹517.1m₹258.1m₹291.1m₹288.8m
Cash and short-term investments₹173.2m₹183.6m₹155.6m₹25.6m₹9.0m₹10.6m₹9.0m
Total liabilities₹141.7m₹141.1m₹144.3m₹158.2m₹160.4m₹208.9m₹201.0m
Debt₹14.6m₹16.8m₹1.3m₹10.6m₹10.2m₹59.7m₹86.7m
Shareholders' equity₹625.4m₹556.0m₹404.5m₹358.8m₹97.7m₹82.2m₹87.8m
Shares outstanding12m13m11m11m11m11m—

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations₹106.0m−₹12.6m₹641,000−₹131.2m₹57.8m₹77.2m₹15.8m
Capital spending−₹84.5m−₹111.5m−₹69.8m−₹31.7m−₹6.8m−₹38.5m−₹89.7m
Free cash flow₹21.6m−₹124.1m−₹69.1m−₹162.9m₹50.9m₹38.7m−₹73.8m
Dividends paid—−₹2.6m−₹2.6m————

Latest quarters

By quarter end

Mar 2025Sept 2024Mar 2024Sept 2023Mar 2023Sept 2022Mar 2022Sept 2021
Revenue₹480.5m₹418.0m₹482.3m₹511.0m₹534.4m₹455.9m₹747.1m₹315.6m
Gross profit₹405.0m₹325.9m₹374.6m₹361.7m₹388.8m₹325.2m₹515.9m₹213.3m
Operating income₹55.2m₹38.3m₹2.6m₹11.0m₹22.0m₹30.0m₹48.0m₹14.4m
Net income₹38.9m₹32.5m₹8.0m₹12.0m₹21.0m₹27.0m₹34.7m₹13.5m
Diluted earnings per share3.173.590.541.201.902.453.301.29
Cash from operations₹39.0m₹66.0m₹34.0m−₹47.0m−₹144.0m₹145.0m−₹137.0m₹6.0m
Capital spending−₹22.0m−₹62.0m−₹42.0m−₹69.0m−₹45.0m−₹25.0m−₹24.0m−₹7.0m
Free cash flow₹17.0m₹4.0m−₹8.0m−₹116.0m−₹189.0m₹120.0m−₹161.0m−₹1.0m
Total assets₹767.1m₹721.0m₹697.1m₹688.0m₹548.8m₹515.0m₹517.1m₹257.8m
Cash and short-term investments₹173.2m₹194.0m₹183.6m₹207.6m₹155.6m₹197.1m₹25.6m₹14.1m
Debt₹14.6m₹11.0m₹16.8m₹40.0m₹1.3m₹3.9m₹10.6m₹17.8m
Shareholders' equity₹625.4m₹589.0m₹556.0m₹548.0m₹404.5m₹386.0m₹358.8m₹111.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.3%3.6%—
Operating income24.8%86.0%—
Net income27.2%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin77.6%74.3%72.8%—
Operating margin5.9%6.0%4.7%—
Net margin4.8%4.8%3.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings49.288.546.054.5
Price to sales3.91.82.22.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 5 Sept 2023.

FY2024FY2023
Paid in the year0.250.25

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.